Dallas biotech Lantern Pharma looks to IPO to fund cancer drug development
Dallas-based biotech Lantern Pharma plans to raise $25 million through an initial public offering to fund development of its cancer...
Dallas-based biotech Lantern Pharma plans to raise $25 million through an initial public offering to fund development of its cancer...
Tuesday's IBD 50 Stocks To Watch pick, pharmaceutical leader Bristol Myers Squibb (BMY), broke out above a new buy point amid...
1.Black R.E. Allen L.H. Bhutta Z.A. et al.Maternal and child undernutrition: global and regional exposures and health consequences.Lancet. 2008; 371:...
RLJ Lodging (RLJ) came out with quarterly funds from operations (FFO) of $0.10 per share, missing the Zacks Consensus Estimate...
New York, May 12, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Medical Marijuana: Consumers’ Perspectives in...
The coronavirus pandemic and resulting recession caught everyone by surprise. Don’t let yourself be surprised again as the world starts...
Virtual focus groups will soon be held as a follow-up to a community needs and health assessment survey that...
Chinese President Xi Jinping chats with President Donald Trump during a welcome ceremony in Beijing on Nov. 9, 2017.AP Photo...
SANTA MONICA, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines...
Darren Wraith pointed out this (currently free access) Springer book by Massimiliano Bonamente [whose family name means good spirit in...
© 2025 researchsnappy.com